发明公开
EP2776021A1 ADMINISTRATION OF A BIS(THIOHYDRAZIDE AMIDE) COMPOUND FOR TREATING CANCERS
审中-公开
一种双（巯基酰胺）化合物用于治疗癌症的施用
- 专利标题： ADMINISTRATION OF A BIS(THIOHYDRAZIDE AMIDE) COMPOUND FOR TREATING CANCERS
- 专利标题（中）： 一种双（巯基酰胺）化合物用于治疗癌症的施用
-
申请号： EP12788085.4申请日： 2012-11-09
-
公开(公告)号： EP2776021A1公开(公告)日： 2014-09-17
- 发明人: SANG, Jim , WADA, Yumiko
- 申请人： Synta Pharmaceuticals Corp.
- 申请人地址： 45 Hartwell Avenue Lexington, MA 02421 US
- 专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人地址： 45 Hartwell Avenue Lexington, MA 02421 US
- 代理机构： Potter Clarkson LLP
- 优先权： US201161558411P 20111110; US201161558412P 20111110
- 国际公布： WO2013071106 20130516
- 主分类号： A61K31/165
- IPC分类号： A61K31/165 ; A61K31/337 ; A61K45/06 ; A61P35/00 ; A61P35/02
摘要：
Administration of a bis(thiohydrazide amide) compound is found to be surprisingly effective at treating subjects with cancer. Methods of treating a subject with cancer comprising continuously administering a bis(thiohydrazide amide) compound, or administering a bis(thiohydrazide amide) compound such that a constant concentration of the compound is achieved in the subject, are disclosed.
信息查询
